SCHEMBL8809964

SCHEMBL8809964

COc1ccc(N(OC(C)=O)OC(C)=O)c(C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
TSHR P16473 2/20 0.43
MEN1 O00255 1/20 0.43
HTT P42858 1/20 0.43
ALDH1A1 P00352 5/20 0.42
HPGD P15428 3/20 0.42
MAPK1 P28482 2/20 0.42
CYP3A4 P08684 2/20 0.42
KEAP1 Q14145 2/20 0.40
NFE2L2 Q16236 2/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
BACE1 P56817 1/20 0.39
F2 P00734 1/20 0.39
GLA P06280 1/20 0.39
KDM4E B2RXH2 4/20 0.39
LMNA P02545 2/20 0.38
MAPT P10636 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CASP1 P29466 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14925281 0.79 KMT2A (0.46) KMT2ATSHRMEN1HTTALDH1A1
SCHEMBL11220698 0.76 KMT2A (0.50) KMT2ATSHRMEN1HTTALDH1A1
SCHEMBL31003335 0.74 ALDH1A1 (0.67) KMT2AMEN1HTTALDH1A1HPGD
SCHEMBL1539315 0.74 ALDH1A1 (0.67) KMT2AMEN1HTTALDH1A1HPGD
SCHEMBL5315078 0.74 CES2 (0.47) HTTALDH1A1HPGDCYP3A4KEAP1
SCHEMBL9020581 0.74 CA12 (0.42) KMT2ATSHRMEN1HTTALDH1A1
SCHEMBL3604278 0.73 POLB (0.42) KMT2ATSHRMEN1HTTKEAP1
SCHEMBL10413873 0.73 KMT2A (0.71) KMT2ATSHRMEN1HTTALDH1A1
SCHEMBL7412320 0.72 HTT (0.43) KMT2ATSHRMEN1HTTALDH1A1
SCHEMBL23139862 0.71 HTT (0.56) KMT2AMEN1HTTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997013750-A1 AZETIDINONES AND THEIR THERAPEUTIC USE AS CYTOKINE INHIBITORS CHIROSCIENCE LIMITED (GB) 1997-04-17 WO disclosed